Cargando…

PB2324: USE OF COMBINATION OF THALIDOMIDE, CYCLOPHOSPHAMIDE AND DEXAMETHASONE IN PATIENTS WITH REFRACTORY/RELAPSED NON-HODGKIN LYMPHOMA: A PALLIATIVE CHEMOTHERAPY STRATEGY.

Detalles Bibliográficos
Autores principales: Martinez, Celia, Yuen, Lisa, Brady, Jessica, Gleeson, Mary, George, Mikhaeel, Stanley, Karen, Paul, Fields, Wrench, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429240/
http://dx.doi.org/10.1097/01.HS9.0000976016.08614.aa
_version_ 1785090662032474112
author Martinez, Celia
Yuen, Lisa
Brady, Jessica
Gleeson, Mary
George, Mikhaeel
Stanley, Karen
Paul, Fields
Wrench, David
author_facet Martinez, Celia
Yuen, Lisa
Brady, Jessica
Gleeson, Mary
George, Mikhaeel
Stanley, Karen
Paul, Fields
Wrench, David
author_sort Martinez, Celia
collection PubMed
description
format Online
Article
Text
id pubmed-10429240
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-104292402023-08-17 PB2324: USE OF COMBINATION OF THALIDOMIDE, CYCLOPHOSPHAMIDE AND DEXAMETHASONE IN PATIENTS WITH REFRACTORY/RELAPSED NON-HODGKIN LYMPHOMA: A PALLIATIVE CHEMOTHERAPY STRATEGY. Martinez, Celia Yuen, Lisa Brady, Jessica Gleeson, Mary George, Mikhaeel Stanley, Karen Paul, Fields Wrench, David Hemasphere Publication Only Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10429240/ http://dx.doi.org/10.1097/01.HS9.0000976016.08614.aa Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Publication Only
Martinez, Celia
Yuen, Lisa
Brady, Jessica
Gleeson, Mary
George, Mikhaeel
Stanley, Karen
Paul, Fields
Wrench, David
PB2324: USE OF COMBINATION OF THALIDOMIDE, CYCLOPHOSPHAMIDE AND DEXAMETHASONE IN PATIENTS WITH REFRACTORY/RELAPSED NON-HODGKIN LYMPHOMA: A PALLIATIVE CHEMOTHERAPY STRATEGY.
title PB2324: USE OF COMBINATION OF THALIDOMIDE, CYCLOPHOSPHAMIDE AND DEXAMETHASONE IN PATIENTS WITH REFRACTORY/RELAPSED NON-HODGKIN LYMPHOMA: A PALLIATIVE CHEMOTHERAPY STRATEGY.
title_full PB2324: USE OF COMBINATION OF THALIDOMIDE, CYCLOPHOSPHAMIDE AND DEXAMETHASONE IN PATIENTS WITH REFRACTORY/RELAPSED NON-HODGKIN LYMPHOMA: A PALLIATIVE CHEMOTHERAPY STRATEGY.
title_fullStr PB2324: USE OF COMBINATION OF THALIDOMIDE, CYCLOPHOSPHAMIDE AND DEXAMETHASONE IN PATIENTS WITH REFRACTORY/RELAPSED NON-HODGKIN LYMPHOMA: A PALLIATIVE CHEMOTHERAPY STRATEGY.
title_full_unstemmed PB2324: USE OF COMBINATION OF THALIDOMIDE, CYCLOPHOSPHAMIDE AND DEXAMETHASONE IN PATIENTS WITH REFRACTORY/RELAPSED NON-HODGKIN LYMPHOMA: A PALLIATIVE CHEMOTHERAPY STRATEGY.
title_short PB2324: USE OF COMBINATION OF THALIDOMIDE, CYCLOPHOSPHAMIDE AND DEXAMETHASONE IN PATIENTS WITH REFRACTORY/RELAPSED NON-HODGKIN LYMPHOMA: A PALLIATIVE CHEMOTHERAPY STRATEGY.
title_sort pb2324: use of combination of thalidomide, cyclophosphamide and dexamethasone in patients with refractory/relapsed non-hodgkin lymphoma: a palliative chemotherapy strategy.
topic Publication Only
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429240/
http://dx.doi.org/10.1097/01.HS9.0000976016.08614.aa
work_keys_str_mv AT martinezcelia pb2324useofcombinationofthalidomidecyclophosphamideanddexamethasoneinpatientswithrefractoryrelapsednonhodgkinlymphomaapalliativechemotherapystrategy
AT yuenlisa pb2324useofcombinationofthalidomidecyclophosphamideanddexamethasoneinpatientswithrefractoryrelapsednonhodgkinlymphomaapalliativechemotherapystrategy
AT bradyjessica pb2324useofcombinationofthalidomidecyclophosphamideanddexamethasoneinpatientswithrefractoryrelapsednonhodgkinlymphomaapalliativechemotherapystrategy
AT gleesonmary pb2324useofcombinationofthalidomidecyclophosphamideanddexamethasoneinpatientswithrefractoryrelapsednonhodgkinlymphomaapalliativechemotherapystrategy
AT georgemikhaeel pb2324useofcombinationofthalidomidecyclophosphamideanddexamethasoneinpatientswithrefractoryrelapsednonhodgkinlymphomaapalliativechemotherapystrategy
AT stanleykaren pb2324useofcombinationofthalidomidecyclophosphamideanddexamethasoneinpatientswithrefractoryrelapsednonhodgkinlymphomaapalliativechemotherapystrategy
AT paulfields pb2324useofcombinationofthalidomidecyclophosphamideanddexamethasoneinpatientswithrefractoryrelapsednonhodgkinlymphomaapalliativechemotherapystrategy
AT wrenchdavid pb2324useofcombinationofthalidomidecyclophosphamideanddexamethasoneinpatientswithrefractoryrelapsednonhodgkinlymphomaapalliativechemotherapystrategy